Metrics to compare | 4DX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4DXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.9x | −2.7x | −0.5x | |
PEG Ratio | 0.04 | 0.01 | 0.00 | |
Price/Book | −84.8x | 1.1x | 2.6x | |
Price / LTM Sales | 414.7x | 6.5x | 3.3x | |
Upside (Analyst Target) | 11.4% | 142.5% | 47.1% | |
Fair Value Upside | Unlock | 18.5% | 6.2% | Unlock |
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in the medical research technology and development of a non-invasive respiratory imaging solution using four-dimensional imaging. It offers CT:VQ, non contrast post processing technology; CAC, a non-contrast cardiothoracic risk assessment sotware; CT LVAS, a regional lung function imaging software; IQ-UIP, a state-of-the-art software; LDAf, Patented Parametric Response Mapping (PRM) technology; LDAi, an automated detection of potential emphysema software; LTA provides visualization and quantification of the lung textures; PHA Analysis, a cutting-edge, fully-automated imaging solution; XV LVAS, a lung airflow imaging software; and XV Scanner, a lung function scanner. The company was incorporated in 2012 and is based in Carlton, Australia.